NHS Branded Framework Agreement – Lot 1 – Tranche A for the North of England and Midlands & East.
Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
Lot 2 – Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with…

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.